Afoxolaner, Moxidectin, And Pyrantel
17 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
17
Total Reports
2
Deaths Reported
1180.0%
Death Rate
Active Ingredients
Afoxolaner, Moxidectin, And Pyrantel
Administration Routes
OralUnknown
Species Affected
Dog 17
Most Affected Breeds
Beagle 2
Lhasa Apso 2
Retriever - Labrador 2
Shepherd Dog - German 2
Terrier - Bull - American Pit 2
Dog (unknown) 1
Greater Swiss Mountain Dog 1
Retriever (unspecified) 1
Boxer (German Boxer) 1
Great Pyrenees 1
Most Reported Reactions
Abnormal radiograph finding 4
Diarrhoea 3
Deafness 3
Vomiting 2
Hyperkalaemia 2
Low sodium-potassium ratio (Na:K ratio) 2
Decreased haemoglobin 2
Leucocytosis NOS 2
Increased urine concentration 2
Elevated protein:creatinine ratio 2
Active urine sediment 2
Adrenal gland tumour 2
Outcome Breakdown
Outcome Unknown
5 (29.4%)
Ongoing
5 (29.4%)
Recovered with Sequela
3 (17.6%)
Recovered/Normal
2 (11.8%)
Died
2 (11.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.